期刊文献+

Torin1调节细胞周期抑制人肝癌HepG2细胞增殖的体外研究

Researd on Torin1 Regulation the Cell Cycle and Inhibition Proliferation of Human Liver Hepatocellular Carcinoma Cell Line(HepG2) in Vetro
下载PDF
导出
摘要 目的研究Torin1对人肝癌Hep G2细胞生长的影响及其可能机制。方法 CCK8法检测不同浓度(0.1,0.5,1.25,2.5,5)μmol·L-1Torin1对Hep G2细胞48h后细胞增殖的影响;流式细胞仪检测不同浓度(1.25,2.5,5)μmol·L-1Torin1处理前后Hep G2细胞周期的变化,Real time PCR和Western blot法检测不同浓度(1.25,2.5,5)μmol·L-1Torin1处理前后Hep G2细胞细胞周期抑制蛋白P27和细胞周期蛋白A1(cyclin A1)mRNA表达水平和蛋白表达水平的变化。结果Torin1作用于Hep G2细胞后,Hep G2细胞增殖明显呈浓度依赖型抑制,1.25,2.5,5μmol·L-1Torin1作用于Hep G2细胞48h后,细胞周期S期明显增多,P27 mRNA和蛋白表达水平呈浓度依赖性增加,cyclin A1 mRNA和蛋白表达水平呈浓度依赖性减少。结论体外应用Torin1可显著抑制人肝癌细胞Hep G2细胞生长,这可能是通过增加抑制细胞周期蛋白P27表达,减少细胞周期蛋白A1的表达来阻碍细胞周期进程。 OBJECTIVE To investigate in vetro the effect of Torin1 on the proliferation and cell cycle on Hep G2 cell line and explore their molecular mechanism. METHODS The anti-proliferative effect on Hep G2 cells was determined by CCK8 assay. The cell cycle was measured by flow cytometry. The Cyclin A1,P27 expression levels of Hep G2 cells treated with Torin1 were detected in mRNA and protein by Real time PCR and Western blot. RESULTS Torin1 could inhibit cell proliferation on Hep G2 cells,and the inhibitory effects were in dose dependent manners. Cell cycle analysis showed that the S phase of Hep G2 cells treated with Torin1 increased significantly compared with the control group. Real time quantitative PCR and Western blot results showed that Torin1 could down-regulate Cyclin A1 expressions( P〈0. 05) and up-regulate p27 expression( P〈0. 05). CONCLUSION Torin1 has the anti-proliferative effect on Hep G2 cells and induce S phase arrest. These effects might be related with proteins associated with cell cycle closely,such as Cyclin A1 and P27.
作者 赵珺 张婧
机构地区 南京医科大学
出处 《海峡药学》 2015年第10期256-258,共3页 Strait Pharmaceutical Journal
关键词 Torin1 细胞周期 CYCLIN A1 P27 Torin1 cellcycle cyclin A1 P27
  • 相关文献

参考文献10

  • 1郑鹏生,冀静.mTOR信号通路与肿瘤的研究进展[J].西安交通大学学报(医学版),2010,31(1):1-9. 被引量:45
  • 2Comas M,Toshkov I,Kuropatwinski KK,Chernova OB,Polinsky A,Blagosklonny MV,Gudkov AV,Antoch MP.New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/-mice by delaying carcinogenesis[J].Aging,2012,4(10):715-722.
  • 3Komarova EA,Antoch MP,Novototskaya LR,Chernova OB,Paszkiewicz G,Leontieva OV,Blagosklonny MV,Gudkov AV.Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/-mice[J].Aging,2012,4(10):709-714.
  • 4Liu Q,Chang JW,Wang J,Kang SA,Thoreen CC,Markhard A,Hur W,Zhang J,Sim T,Sabatini DM,Gray NS.Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent,selective mammalian target of rapamycin(m TOR)inhibitor for the treatment of cancer[J].Journal ofMedicinal Chemistry,2010,53(19):7146-7155.
  • 5Francipane MG,Lagasse E.Selective targeting of human colon cancer stem-like cells by the m TOR inhibitor Torin-1[J].Oncotarget,2013,4(11):1948-62.
  • 6Li C,Lee PS,Sun Y,Gu X,Zhang E,Guo Y,Wu CL,Auricchio N,Priolo C,Li J,Csibi A,Parkhitko A,Morrison T,Planaguma A,Kazani S,Israel E,Xu KF,Henske EP,Blenis J,Levy BD,Kwiatkowski D,Yu JJ.Estradiol and m TORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells[J].J Exp Med,2014,211(1):15-28.
  • 7Choe G,Horvath S,Cloughesy TF,Crosby K,Seligson D,Palotie A,Inge L,Smith BL,Sawyers CL,Mischel PS.Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo[J].Cancer Res,2003,63(11):2742-6.
  • 8Neve RM,Holbro T,Hynes NE.Distinct roles for phosphoinositide 3-kinase,mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells[J].Oncogene,2002,21(29):4567-76.
  • 9Philp AJ1,Campbell IG,Leet C,Vincan E,Rockman SP,Whitehead RH,Thomas RJ,Phillips WA.The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors[J].Cancer Res,2001,61(20):7426-9.
  • 10杨伟红,吴绪峰,陈惠祯.Cyclin A、p27在卵巢肿瘤中的表达及临床意义[J].肿瘤,2005,25(2):177-179. 被引量:4

二级参考文献8

  • 1Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia[J]. Am J Pathol, 1995, 147(3) :545-603.
  • 2Paterlini P, Flejou JF, De Mitri MS, et al. Structure and expression of the cyclin A gene in human primary liver cancer.Correlation with flow cytometric parameters [J]. J Hpatol,1995, 23(1) :47-52.
  • 3Dobashi Y, Shoji M, Jiang SX, et al. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas[J]. Am J Pathol, 1998, 153(3) :963-972.
  • 4Lotayef M,Wilson GD, Daley FM,et al. Aberrant expression of cyclin A in head and neck cancer[J]. Br J Cancer, 2000, 83(1):30-34.
  • 5Yasunaga M,Tabira Y, Nakano K,et al. Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma[J].Ann Thorac Surg, 2000, 70 (5): 1634-1640.
  • 6Sui L,Tokuda M,Ohno M,et al. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors[J]. Gynecol Oncol, 1999, 73(2) :202-209.
  • 7Sui L,Dong Y,Ohno M,et al. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors[J]. Gynecol Oncol, 2001, 83(1) :56-63.
  • 8Choe G,Horvath S,Cloughesy TF,Crosby K,Seligson D,Palotie A,Inge L,Smith BL,Sawyers CL,Mischel PS.Analysis of the phosphatidylinosit ol 3'-kinase signaling pathway in glioblastoma patients in vivo[J].癌症,2003,22(7):766-766. 被引量:42

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部